Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonghua Jinkaiwei Pharmaceutical is a Chinese pharmaceutical company headquartered in Tonghua, Jilin Province, specializing in the research, development, and manufacturing of both traditional Chinese medicines (TCM) and chemical pharmaceuticals. Established in 2001, the company's product portfolio covers a wide range of therapeutic areas, including respiratory health, cardiovascular diseases, and gastrointestinal disorders. It operates large-scale manufacturing facilities that comply with national Good Manufacturing Practice (GMP) standards for various dosage forms such as capsules, tablets, and granules. Key products include treatments for the common cold, such as Compound Paracetamol and Amantadine Hydrochloride capsules, as well as specialized TCM formulations. Tonghua Jinkaiwei is primarily focused on the domestic Chinese market, providing essential medicines to healthcare providers and pharmacies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tonghua Jinkaiwei Pharmaceutical.